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Long-Term Visual Functioning After
Eclampsia
Marjon J. Wiegman, BSc, Jan C. de Groot, MD, PhD, Nomdo M. Jansonius, MD, PhD,
Jan G. Aarnoudse, MD, PhD, Henk Groen, MD, PhD, Marijke M. Faas, PhD,
and Gerda G. Zeeman, MD, PhD
OBJECTIVE: Complete neurocognitive recovery after ec-
lampsia has been questioned with the expression of
neurocognitive deficits by affected women and demon-
stration of cerebral white matter lesions on magnetic
resonance imaging years after eclampsia. We hypothe-
sized that formerly eclamptic women may experience
impaired vision-related quality of life (QOL) and visual
field loss as a result of the presence of such lesions in the
cerebral visual areas.
METHODS: Using the National Eye Institute Visual Func-
tion Questionnaire-39/Nederlands questionnaire, vision-
related QOL was compared between formerly eclamptic
women and control participants after normotensive
pregnancies. Furthermore, in formerly eclamptic women,
visual fields were assessed using automated perimetry,
and presence of white matter lesions was evaluated using
cerebral magnetic resonance imaging. Presence of a
relationship between these lesions and National Eye
Institute Visual Function Questionnaire-39/Nederlands
scores was estimated.
RESULTS: Forty-seven formerly eclamptic women and 47
control participants participated 10.15.2 and 11.57.8
years after their index pregnancy, respectively. Compos-
ite scores and 4 out of 12 National Eye Institute Visual
Function Questionnaire-39/Nederlands subscale scores
were significantly lower in formerly eclamptic women
than in control participants (P<.01 for composite scores).
This could not be explained by visual field loss, because
all formerly eclamptic women who underwent perimetry
(n43) demonstrated intact visual fields. White matter
lesions were present in 35.7% of formerly eclamptic
women who underwent magnetic resonance imaging
(n42) and were associated with lower vision-related
QOL scores (P<.05 for composite scores).
CONCLUSION: Formerly eclamptic women express
lower vision-related QOL than control participants,
which seemed at least partly related to the presence of
white matter lesions. However, such women do not have
unconscious visual field loss. Vision-related QOL impair-
ment expressed by formerly eclamptic women may




LEVEL OF EVIDENCE: II
Visual disturbances are relatively common duringthe acute phase of eclampsia, including transient
cortical blindness, scotomata, visual neglect, and blurred
vision, and can often be attributed to the presence of
cerebral edema.1 Although the exact pathophysiology of
eclampsia remains to be elucidated, it is considered to
be an expression of the posterior reversible encephalop-
athy syndrome.2 As its name suggests, this syndrome is
thought to be a completely reversible condition. How-
ever, the reversibility of this syndrome, and eclampsia in
particular, has been questioned lately.3 In previous
studies, one-fourth of eclamptic women showed persis-
tent cerebral white matter lesions and brain tissue loss
on magnetic resonance imaging (MRI) 6 weeks postpar-
From the School of Behavioral and Cognitive Neurosciences, the Departments of
Obstetrics and Gynecology, Radiology, Ophthalmology, and Epidemiology, and
the Division of Medical Biology, Department of Pathology and Medical Biology,
University of Groningen, University Medical Center Groningen, Groningen, The
Netherlands.
The authors thank Anne Marijn van der Graaf and Nina Roos for assistance
with gathering data of visual field assessments and vision-related QoL question-
naires; and Annemieke Bolte and Jim van Eyck for identifying formerly eclamptic
women in the database of the VU Medical Center and Isala Clinics, respectively,
and facilitating the extraction of data from the medical records of these women.
Presented as a poster at the XVII ISSHP World Congress, October 3–6, 2010,
Melbourne, Australia, and as an oral presentation at the EuroISSHP Congress,
October 5–7, 2011, Rome, Italy.
Corresponding author: Marjon J. Wiegman, BSc, University of Groningen, Univer-
sity Medical Center Groningen, Department of Obstetrics & Gynecology, Hanzeplein
1, 9700 RB Groningen, The Netherlands; e-mail: mj.wiegman@umcg.nl.
Financial Disclosure
The authors did not report any potential conflicts of interest.
© 2012 by The American College of Obstetricians and Gynecologists. Published
by Lippincott Williams & Wilkins.
ISSN: 0029-7844/12
VOL. 119, NO. 5, MAY 2012 OBSTETRICS & GYNECOLOGY 959
tum.4,5 Furthermore, several years after eclampsia, such
lesions are more prevalent in formerly eclamptic
women compared with women with normotensive
pregnancies.6
In general, visual disturbances expressed by pa-
tients with posterior reversible encephalopathy syn-
drome or eclampsia are known to be transient. How-
ever, permanent visual field abnormalities, in
particular hemianopia, but also permanent blindness,
have been described and are thought to be related to
persistent lesions in the visual cortex.3,7 Moreover, in
a Scandinavian follow-up study, 11% of formerly
eclamptic women reported persistent visual distur-
bances.8 However, median follow-up time of these
studies was relatively short, being less than 1 year.
When located in the visual pathway from the
optic nerve to optic radiation, white matter lesions
may cause (un)conscious visual field defects or im-
pairment of higher-order visual functions such as
visual perception and spatial orientation. Visual dis-
turbances might be a contributing factor related to
persistent complaints described by some formerly
eclamptic women such as poor concentration and
limited attention span.8,9 We hypothesized that years
after eclampsia decreased vision-related quality of life
(QOL) and visual field loss may be experienced as a
result of the presence of white matter lesions in the
cerebral visual areas. We choose to use a validated
vision-related QOL questionnaire to evaluate these
women’s own perception of daily functioning in rela-
tion to vision. The questionnaire determines the influ-
ence of visual disability and visual symptoms on generic
health domains such as emotional well-being and social
functioning in addition to task-oriented domains related
to daily visual functioning. Subsequently, the relation-
ship of this self-perceived vision-related QOL with the
prevalence of visual field defects and cerebral white
matter lesions was assessed.
MATERIALS AND METHODS
Women with a diagnosis of eclampsia in their medical
history between 1988 and 2008 were identified in the
University Medical Center Groningen, VU Univer-
sity Medical Center Amsterdam and Isala Clinics
Zwolle. These hospitals are teaching hospitals that
serve as tertiary perinatal referral hospitals in The
Netherlands. Eclampsia was defined according to the
definition of the International Society for the Study of
Hypertension in Pregnancy.10 Exclusion criteria in-
cluded pre-existing glaucoma or other conditions
known to be related to visual field defects, epilepsy or
other neurological disorders including a known cere-
brovascular accident, intracranial infections, or a his-
tory of any cranial neurosurgical procedure. Also,
current pregnancy and an age of younger than 18
years were used as exclusion criteria.
In the three participating hospitals, electronic
admission, diagnosis, and delivery databases are kept
up to date, which were used to identify eligible study
participants (Fig. 1). In total, 133 women were diag-
nosed with eclampsia in these three hospitals between
1988 and 2008. In addition, six women who delivered
in other hospitals than the participating clinics and
who had heard about this study requested to partici-
pate in the current study, which was allowed.
Medical records were reviewed for accuracy of
diagnosis of eclampsia and to extract clinical and
demographic characteristics. On review, one woman
was excluded because a diagnosis of eclampsia could
not be confirmed. Three women were described as
having had generalized myoclonic twitches while
remaining conscious. Because these twitches suggest
cerebral involvement, these women were not ex-
cluded from the study although they had not experi-
enced tonic–clonic seizures. Four women had died in
the interim, two of whom as a result of cerebral
complications resulting from eclampsia, one resulting
from breast cancer, and one attributable to cervical
cancer years after her pregnancy. Four other women
were excluded, two women as a result of a current
pregnancy, one because of a cerebrovascular acci-
dent, and one because she did not speak Dutch.
This resulted in 130 formerly eclamptic women
who were eligible to participate. These women re-
ceived a written invitation for participation in this
study. Of these women, 47 women could be reached
and were willing to participate. Several women, who
decided not to take part in the study, mentioned travel
distance and time commitment as the main reason for
nonparticipation. Some other women did not want to
be confronted with their medical history.
In addition to these formerly eclamptic women, 47
parous control women who had normotensive pregnan-
cies participated in this study (Fig. 1). These women
were recruited among hospital personnel of the Univer-
sityMedical Center Groningen. In total, 80 such women
were randomly selected and invited to participate, of
which 50 decided to take part in the study. One of them
was excluded as a result of a history of hypertension in
pregnancy. An additional two had to be excluded as a
result of ophthalmologic conditions known to be asso-
ciated with visual field impairment.
Both formerly eclamptic and control participants
filled out a questionnaire related to their obstetric and
current and past medical history. Approval for this
project was obtained from the Medical Ethics Commit-
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tee of the University Medical Center Groningen, and
informed consent was obtained from the participants.
Vision-specific health-related QOL was com-
pared between formerly eclamptic and parous control
participants using the validated Dutch translation of
the National Eye Institute Visual Function Question-
naire-39/Nederlands.11 The English version of this
questionnaire was developed at RAND Health under
the sponsorship of the National Eye Institute and was
designed to measure the dimensions of self-reported
vision targeted health status.
The National Eye Institute Visual Function Ques-
tionnaire-39/Nederlands consists of a base set of 25
questions and 14 additional questions generating the
following vision-targeted subscales: general health,
general vision, near and distance activities, driving
difficulties, peripheral vision, color vision, ocular
pain, vision-related role function, vision-related de-
pendency, vision-related social functioning, and vi-
sion-related mental health. Each question was scored
on a 0 to 100 scale with 0 being the worst and 100
being the best possible score. Each subscale score was
calculated by averaging the scores of the questions
that constitute that particular subscale. The composite
score was calculated by averaging all vision-targeted
subscale scores, excluding the general health sub-
score.
The National Eye Institute Visual Function Ques-
tionnaire-39/Nederlands was filled out by 46 formerly
eclamptic women, of which 42 had participated in
visual field testing. One of the women, who had
undergone perimetry and MRI, did not return the
questionnaire. Three women filled out the question-
naire but did not participate in visual field testing as a
result of travel distances. Results were compared with
scores from 47 parous control women, who partici-
pated in vision-related QOL assessment only.
The prevalence of visual field defects was as-
sessed in 43 formerly eclamptic women at the Depart-
ment of Ophthalmology of the University Medical
Center Groningen using automated perimetry. The
control group did not undergo visual field testing as a
result of an expected very low prevalence of visual
field defects in these participants. This presumption
was based on data from the Rotterdam Study, which
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Fig. 1. Flow diagram illustrating the inclusion and exclusion process of study participants. A. The selection of formerly
eclamptic women. B. The selection of control participants. *Forty-two of these women returned the National Eye Institute
Visual Function Questionnaire-39 (NEI-VFQ-39/NL). †Forty-one of these women returned the NEI-VFQ-39/NL.
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general elderly population (55–64 years).12 In our
group of healthy women of on average 40 years old,
the prevalence of visual field defects would likely be
less than 3% and probably even closer to 1%. Based
on literature indicating approximately a 50% preva-
lence of visual field defects in patients with former
stroke,13 we anticipated that at least 25% of formerly
eclamptic women who demonstrate cerebral white
matter lesions would experience some degree of
visual field loss. Although a formal power calculation
could not be performed as a result of lack of available
data in the literature, we considered the number of 43
formerly eclamptic women to evaluate whether the
prevalence of visual field loss in such women is
clinically relevant.
An assistant of the Department of Obstetrics and
Gynecology was trained by a certified technician in
conducting automated perimetry using the Humphrey
Field Analyzer. The visual field was tested with a
52-point suprathreshold test that covered the central
visual field with a radius of 24°, a test identical to the
test used in the Rotterdam Study.14 Visual field loss
was defined as nonresponse to a light stimulus of 6 dB
above a threshold-related estimate of the hill of vision
in at least three contiguous test points or four includ-
ing the blind spot.
Visual field testing was performed on one eye at
a time with the contralateral eye covered. The patient
was asked to look straight ahead while lights were
projected at different places in the perimeter. Partic-
ipants were instructed to click a button every time
they noticed a projected light.
Test reliability was evaluated using the reliability
indices for false-positive and false-negative answers;
fixation stability was observed by the perimetrist. In
case of visual field loss or an unreliable test result
(more than 33% false-positive or false-negative catch
trials or poor fixation as observed by the perimetrist),
the test was repeated in the same session after a break.
Visual field loss on an initial test is, as a result of a
learning effect, quite common and should always be
confirmed or falsified.15
Cerebral MRI was performed in 42 of the 47
formerly eclamptic participants as part of an ongoing
follow-up study assessing white matter lesions after
eclampsia.6 These MRI scans were made on a 3-Tesla
MRI system using the following sequences: T1, T2,
proton density, and fluid-attenuated inversion recov-
ery. The presence of white matter lesions was rated by
an experienced neuroradiologist as previously de-
scribed.6,16 Briefly, such lesions were considered pres-
ent if hyperintense on T2- and proton density-
weighted images and not hypointense on T1-
weighted images. The presence of subcortical white
matter lesions was evaluated for the following locations:
frontal, parietal, temporal, occipital and insular lobe,
brain stem, and cerebellum. To correct for inclusion of
partial volume, women with two small white matter
lesions or less were considered as negative. Descrip-
tive statistics such as demographic information and
scores on the National Eye Institute Visual Function
Questionnaire-39/Nederlands were presented as
meansstandard deviations for continuous variables
and percentages for dichotomous variables.
Demographic data and National Eye Institute
Visual Function Questionnaire-39/Nederlands sub-
scale and composite scores were compared between
formerly eclamptic and control women using Fisher’s
exact test, independent Student’s t test, or Mann-
Whitney U tests, where appropriate. The relation
between National Eye Institute Visual Function Ques-
tionnaire-39/Nederlands scores and presence of white
matter lesions was assessed using Mann-Whitney U
tests. Differences were considered statistically signifi-
cant at P.05. Data analyses were performed using
SPSS for Windows 18.
RESULTS
In this study, 47 formerly eclamptic women partici-
pated. Of these women, 46 completed the National
Eye Institute Visual Function Questionnaire-39/Ned-
erlands, 43 underwent perimetry, and 42 underwent
cerebral MRI. In total, 47 parous control women who
did not experience a hypertensive pregnancy filled
out the National Eye Institute Visual Function Ques-
tionnaire-39/Nederlands.
Table 1 shows baseline characteristics of the
study participants. Mean age and elapsed time since
Table 1. Characteristics of Formerly Eclamptic





Age (y) 40.37.0 41.78.1 .362














Data are meanstandard deviation or % (95% confidence
interval) unless otherwise specified.
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index pregnancy at the time of participation were
similar for both groups. Also, the percentage of white
women and nulliparity at the time of index pregnancy
were comparable between the groups. However, as
may be expected, birth weight and estimated gesta-
tional age at delivery were significantly lower in
formerly eclamptic women compared with parous
control participants.
Vision-related QOL may be influenced by visual
field defects and impairment of higher-order visual
functions and therefore was assessed in formerly
eclamptic women and parous control participants.
Compared with parous control participants, formerly
eclamptic women had significantly lower composite
scores as well as lower scores on all subscales. This
difference was significant for the composite of the
National Eye Institute Visual Function Question-
naire-39/Nederlands and for four of 12 subscales,
specifically, general health, vision-related social func-
tioning, driving, and peripheral vision (Table 2). For
the subscales general vision, ocular pain, near and
distance activities, vision-related mental health, vi-
sion-related role function, vision-related dependency,
and color vision, the differences did not reach signif-
icance (Table 2).
Automated perimetry was performed in 43 for-
merly eclamptic women. At the first examination,
nine of these women showed abnormal test results in
at least one eye and one had an unreliable test result.
On the repeat test, all had a reliable test result and
none showed visual field defects.
In total, 42 formerly eclamptic participants un-
derwent MRI, of which 15 (35.7%, 95% confidence
interval [CI] 21.2–50.2%) demonstrated white matter
lesions. All but two of these women (86.7%, 95% CI
69.5–100.0%) had these lesions in the frontal lobe and
some in the parietal lobe (n4; 26.6%, 95% CI
4.2–49.0%), insular lobe (n3; 20.0%, 95% CI 0.0–
40.2%), or cerebellum (n1; 6.7%, 95% CI 0.0–
19.4%). No lesions were observed in the occipital,
temporal lobe, or brain stem. Five formerly eclamptic
women demonstrated white matter lesions in multiple
brain regions (33.3%, 95% CI 9.5–57.2%).
Magnetic resonance imaging scans were available
for 41 of the formerly eclamptic participants who also
filled out the National Eye Institute Visual Function
Questionnaire-39/Nederlands. For three women, no
scans were available as a result of general contraindi-
cations for MR scanning and another two participants
waived participation in MRI scanning as a result of
travel distance. Fourteen (34.1%, 95% CI 19.6–
48.6%) formerly eclamptic women who participated
in the National Eye Institute Visual Function Ques-
tionnaire-39/Nederlands demonstrated white matter
lesions. These women had lower subscale scores
compared with formerly eclamptic women without
lesions, except for the subscale color vision (Table 3).
This difference was significant for the subscales gen-
eral vision, near activities, vision-related role function,
and peripheral vision. In addition, formerly eclamptic
women with white matter lesions had a significantly
Table 2. National Eye Institute Visual Function
Questionnaire-39 Subscale and
Composite Scores of Formerly Eclamptic





General health 67.315.8 74.714.0 .027
General vision 80.511.2 83.39.3 .175
Ocular pain 86.117.1 90.212.8 .380
Near activities 93.29.4 94.96.1 .508
Distance activities 92.910.4 96.54.1 .362
Social functioning 98.35.1 100.00.0 .006
Mental health 90.212.1 93.57.5 .181
Role function 92.412.8 95.97.1 .327
Dependency 98.93.0 99.52.9 .142
Driving 75.614.8 85.911.1 .001
Color vision 98.48.2 100.00.0 .151
Peripheral vision 90.817.0 98.48.1 .002
Composite score 90.97.8 94.53.5 .005
Data are meanstandard deviation unless otherwise specified.
Table 3. National Eye Institute Visual Function
Questionnaire-39 Subscale and
Composite Scores of Formerly Eclamptic










General health 62.5 (32.5–100.0) 65.0 (32.5–100.0) .173
General vision 75.0 (60.0–85.0) 85.0 (60.0–100.0) .010
Ocular pain 87.5 (37.5–100.0) 87.5 (50.0–100.0) .530
Near activities 91.7 (70.8–100.0) 95.8 (50.0–100.0) .037
Distance
activities
91.7 (66.7–100.0) 100.0 (58.3–100.0) .115
Social
functioning
100.0 (91.7–100.0) 100.0 (70.0–100.0) .192
Mental health 90.0 (70.0–100.0) 95.0. (45.0–100.0) .175
Role function 90.6 (56.3–100.0) 100.0 (50.0–100.0) .028
Dependency 100.0 (93.8–100.0) 100.0 (87.5–100.0) .460
Driving 66.7 (58.3–91.7) 75.0 (50.0–100.0) .377
Color vision 100.0 (75.0–100.0) 100.0 (50.0–100.0) .659
Peripheral vision 87.5 (50.0–100.0) 100.0 (25.0–100.0) .045
Composite score 86.3 (72.7–97.5) 95.3 (62.0–100.0) .035
Data are median (range) unless otherwise specified.
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lower composite score compared with those without
lesions.
DISCUSSION
Women who have experienced eclampsia report
lower vision-related QOL on average 10 years after
the index pregnancy compared with parous control
participants who had normotensive pregnancies. In
formerly eclamptic women, lower vision-related
QOL was associated with the presence of cerebral
white matter lesions. Because visual fields of these
women were intact when examined by perimetry, this
suggests that lower vision-related QOL was not the
result of (un)conscious visual field loss related to white
matter lesions.
Visual disturbances are relatively common dur-
ing the acute phase of eclampsia, attributed to the
presence of reversible cerebral vasogenic edema,
mainly in the (sub)cortical parieto-occipital and tem-
poral regions.17,18 The fact that a substantial percent-
age of formerly eclamptic women expresses persistent
neurocognitive deficits and demonstrates white mat-
ter lesions6 stimulated us to examine the possibility
that these lesions could be associated with (un)con-
scious visual field loss.
Unawareness of visual field loss is a commonly
described phenomenon19,20 and can be attributed to
occurrence of perceptual filling-in, in which missing
information of a visual field defect is inferred from the
surrounding intact visual field.21 In addition, several
animal studies have shown a marked potential for
brain plasticity in response to both retinal and cortical
lesions.22,23 Interestingly, also human studies show
evidence for (partly) functional recovery of visual
field loss after cerebral scotomata.24–26 Therefore,
although formerly eclamptic women in our study did
not demonstrate visual field loss on perimetry, one
could hypothesize that small visual field defects might
have been present in the period directly after the
acute phase of eclampsia. We assessed visual fields
years after eclampsia, a timeframe that might have
allowed for rearrangement of visual pathways affected
by white matter lesions. Hence, especially small visual
field defects may have shrunken to undetectable
abnormalities.27
Absence of identifiable lesions in the visual path-
way from the optic nerve to optic radiation of our
participants can obviously also explain a true absence
of visual field defects after eclampsia. It seems plau-
sible that white matter lesions after eclampsia are
mainly located in the parieto-occipital region because
vasogenic edema during the acute phase of eclampsia
is most commonly observed here.2 This edema, when
severe enough, has been suggested to decrease re-
gional cerebral perfusion pressure and blood flow to
ischemic levels leading to areas of cytotoxic edema
and infarction.28 However, this study demonstrated
only a few women with parietal white matter lesions
and absence of such lesions in both the occipital and
temporal lobe. Interestingly, white matter lesions
were located in the frontal lobe in the majority of
women with lesions. Because the primary visual cor-
tex is located within the occipital lobe, these results
can well explain the absence of visual field loss in
formerly eclamptic women. Furthermore, the location
of white matter lesions suggests a different or addi-
tional etiology of these lesions other than ischemia
resulting from vasogenic edema. As a result of the
relatively small group of lesion-positive women, fur-
ther research addressing lesion location and its etiol-
ogy after eclampsia is required.
Vision-related QOL was assessed using the Na-
tional Eye Institute Visual Function Questionnaire-
39/Nederlands, a commonly used questionnaire in
the field of ophthalmology. A broad spectrum of
ocular conditions has been shown to potentially alter
vision-related QOL as measured by the National Eye
Institute Visual Function Questionnaire-39/Neder-
lands, including glaucomatous and poststroke visual
field loss,29,30 congenital cataract,31 and diabetic reti-
nopathy.32 In contrast with the objective visual field
assessment as a measure of visual function, the Na-
tional Eye Institute Visual Function Questionnaire-
39/Nederlands comprises aspects of daily functioning
in relation to vision strictly from a participant’s per-
spective. In addition to lower National Eye Institute
Visual Function Questionnaire-39/Nederlands com-
posite scores in formerly eclamptic women, subscale
scores related to general health, driving, peripheral
vision, and vision-related social functioning were
lower as well. This lower vision-related QOL ap-
peared to be at least partly related to the presence of
white matter lesions in formerly eclamptic women
because women who demonstrated such lesions had a
lower composite score as well as lower scores on
one-third of the subscales compared with those with-
out lesions. It should be noted that additional smaller,
but still relevant, differences in subscale scores between
the groups may have been missed as a result of insuffi-
cient power. However, although the number of women
evaluated in this project may appear limited, in the
context of the rare incidence of eclampsia, this study is
considered sizeable.
The underlying mechanism by which white mat-
ter lesions might lead to lower vision-related QOL is
still speculative at this moment because visual fields
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were intact. A possible explanation is that these
lesions may interfere with neurocognitive functioning
pertaining to higher-order visual functions, which
might subsequently result in lower vision-related
QOL and commonly reported complaints of formerly
eclamptic women such as difficulties with reading texts.
The majority of lesions in formerly eclamptic women
appeared to be located in the frontal and parietal lobe,
which are involved in higher-order visual functions,
including visual memory and visuospatial process-
ing.33–35 Future research is needed to objectively assess
such higher-order functions in formerly eclamptic and
control women using a detailed neurocognitive test
battery.
A few limitations of the current study should be
noted. First, as a result of the retrospective nature of
this study, no data are available on visual functioning
before the index pregnancy. However, a prospective
study design seems unfeasible in view of the rare
incidence of eclampsia. Second, management and
outcome of eclamptic women may have changed in
the period during which our participants had eclamp-
sia. However, this long period was required to obtain a
sizeable study population, especially because the partic-
ipation rate of eclamptic women was relatively low.
In conclusion, formerly eclamptic women have
lower vision-related QOL, which seemed associated
with the presence of cerebral white matter lesions.
Because these lesions did not appear to induce visual
field loss, further research is needed to unravel the
underlying mechanism of lower vision-related QOL
and its relationship with white matter lesions. How-
ever, our results are in line with the current doubts
about the complete reversibility of eclampsia. In
addition to earlier proposed long-term sequelae per-
taining to self-perceived neurocognitive functioning,
eclampsia may also affect visual functioning years
after the complicated pregnancy.
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